Reset filter
Keywords
Off-Treatment ×
Show more Keywords
Table of contents
  1. 1. Clinical Trial
  2. 2. Routine Documentation
  3. 3. Registry/Cohort Study
  4. 4. Quality Assurance
  5. 5. Data Standard
  6. 6. Patient-Reported Outcome
  7. 7. Medical Specialty
    1. 7.1. Anesthesiology
    1. 7.2. Dermatology
    1. 7.3. ENT
    1. 7.4. Geriatrics
    1. 7.5. Gynecology/Obstetrics
    1. 7.6. Internal Medicine
      1. Hematology
      1. Infectious Diseases
      1. Cardiology/Angiology
      1. Pneumology
      1. Gastroenterology
      1. Nephrology
      1. Endocrinology/Metabolic Diseases
      1. Rheumatology
    1. 7.7. Neurology
    1. 7.8. Ophthalmology
    1. 7.9. Palliative Care
    1. 7.10. Pathology/Forensics
    1. 7.11. Pediatrics
    1. 7.12. Psychiatry/Psychosomatics
    1. 7.13. Radiology
    1. 7.14. Surgery
      1. General/Visceral Surgery
      1. Neurosurgery
      1. Plastic Surgery
      1. Thoracic Surgery
      1. Trauma/Orthopedics
      1. Vascular Surgery
    1. 7.15. Urology
    1. 7.16. Dental Medicine/OMS
Selected data models

You must log in to select data models for download or further analysis.

26 Search results.

Relevance Rating New first Old first

Bladder Cancer NCT00014534 Treatment - CALGB: 90104 Off Treatment Notice Revised - 2169415v3.0 - CALGB: 90104 Off Treatment Notice Revised

- 1/9/15 - 1 form, 1 itemgroup, 20 items, 1 language
Itemgroup: CCRR MODULE
CALGB: 90104 Off Treatment Notice Revised Combination Chemotherapy in Treating Patients With Bladder Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=BE1B4CED-A464-70DB-E034-0003BA12F5E7

Breast Cancer NCT01242800 Off Treatment - E2108 End-of-Study Form - 3128917v1.0 - E2108 End-of-Study Form

- 1/9/15 - 1 form, 6 itemgroups, 21 items, 1 language
Itemgroups: Header Module,Header,Amended Data,Vital Status,Section I,Comments
E2108 End-of-Study Form Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=8DF34112-9349-8BCA-E040-BB89AD4347FD

Brain and Central Nervous System Tumors NCT00053963 Off Treatment - Off Protocol Therapy Follow-up (OPTF) Report (Master) [ADVL0212] - 2077867v3.0 - Off Protocol Therapy Follow-up (OPTF) Report (Master) [ADVL0212]

- 1/9/15 - 1 form, 4 itemgroups, 28 items, 1 language
Itemgroups: Header,Patient Status Information,Events of Interest,CCRR MODULE
Off Protocol Therapy Follow-up (OPTF) Report (Master) [ADVL0212] FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B24316ED-D5DA-16A3-E034-0003BA12F5E7

North Central Cancer Treatment Group End of Active Treatment Form NCT00377156

- 6/8/15 - 1 form, 2 itemgroups, 15 items, 1 language
Itemgroups: Header,Preregistration Screening Failure
North Central Cancer Treatment Group End of Active Treatment Form NCT00377156 Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=10B2740B-6134-4AA3-E044-0003BA3F9857

Neuroblastoma NCT00053326 Off Treatment - ANBL0321 Off Protocol Therapy Follow-up (OPTF) Report (Master) - 2089607v3.0 - ANBL0321 Off Protocol Therapy Follow-up (OPTF) Report (Master)

- 1/9/15 - 1 form, 4 itemgroups, 26 items, 1 language
Itemgroups: Header,Patient Status Information,Events of Interest,CCRR MODULE
ANBL0321 Off Protocol Therapy Follow-up (OPTF) Report (Master) Fenretinide in Treating Children With Recurrent or Resistant Neuroblastoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B9B484F8-51DB-1EF7-E034-0003BA12F5E7

Brain and Central Nervous System Tumors NCT00890747 Off Treatment - AMC-061 Off Protocol Treatment Summary Form (F05) - 2934968v1.0 - AMC-061 Off Protocol Treatment Summary Form (F05)

- 1/8/15 - 1 form, 1 itemgroup, 4 items, 1 language
Itemgroup: Off-Protocol Treatment Summary
AMC-061 Off Protocol Treatment Summary Form (F05) Sunitinib Malate in Treating HIV-Positive Patients With Cancer Undergoing Highly Active Antiretroviral Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=71988CF7-F855-68F0-E040-BB89AD4358A1

ECOG Off-Treatment Form NCT00110019

- 6/16/15 - 1 form, 3 itemgroups, 22 items, 1 language
Itemgroups: ECOG clinical trial administrative data,Vital Status,Comments
ECOG Off-Treatment Form NCT00110019 Carboplatin and Paclitaxel With or Without Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Melanoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=E75D701E-FC7C-3DEF-E034-0003BA3F9857

E1609 Off-Treatment Form NCT01274338

- 6/16/15 - 1 form, 6 itemgroups, 24 items, 1 language
Itemgroups: Header Module,Patient demographics,Vital Status,Section I,Section II,Footer Module
E1609 Off-Treatment Form NCT01274338 Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=97EE3297-340E-F402-E040-BB89AD436AF2

E3F05 Off-Treatment Form NCT00978458

- 6/12/15 - 1 form, 8 itemgroups, 26 items, 1 language
Itemgroups: Header Module,Patient demographics,Data amendment,Vital Status,Protocol treatment,Section I,Section II,Comments
E3F05 Off-Treatment Form NCT00978458 Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=6C1889F9-CF7D-5474-E040-BB89AD431A23

North Central Cancer Treatment Group N0577 End Of Active Treatment/Cancel Notification Form NCT00887146

- 6/8/15 - 1 form, 2 itemgroups, 16 items, 1 language
Itemgroups: Header Module,Preregistration Screening Failure
North Central Cancer Treatment Group N0577 End Of Active Treatment/Cancel Notification Form (Submit Once Per Patient) NCT00887146 Radiation Therapy or Radiation Therapy and Temozolomide or Temozolomide Alone in Treating Patients With Newly Diagnosed Anaplastic Glioma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=4C090D31-BAA2-2FAA-E044-0003BA3F9857

ANBL0321: Death Worksheet NCT00053326

- 7/5/15 - 1 form, 3 itemgroups, 17 items, 1 language
Itemgroups: Header,Death Assessment,CCRR MODULE
ANBL0321: Death Worksheet NCT00053326 Fenretinide in Treating Children With Recurrent or Resistant Neuroblastoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=B9B55D16-FD2B-1EE8-E034-0003BA12F5E7

Sunitinib in HIV with Cancer NCT00890747 AMC-061 - Off Study Summary Form (F50)

- 6/20/17 - 1 form, 1 itemgroup, 4 items, 1 language
Itemgroup: Off-Study Summary
AMC-061 Off Study Summary Form (F50) Sunitinib Malate in Treating HIV-Positive Patients With Cancer Undergoing Highly Active Antiretroviral Therapy https://clinicaltrials.gov/ct2/show/NCT00890747

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial